Cabell Christopher
SEC CIK 1814928 · EDGAR
Most active insiders at IKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SANDS FRANK M. | 10% | $3.00M | — |
| 2 | Cabell Christopher | Pres, Head of R, D | — | — |
| 3 | Aurentz Vincent | Dir | — | — |
| 4 | Munshi Amit | Dir | — | — |
| 5 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | — |
| 6 | BERMAN DENNIS N | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-24 | 2026-02-21 | IKT | Inhibikase Therapeutics, Inc. | Cabell Christopher | Pres, Head of R, D | D - Sale to Iss | $0.00 | -338.3K | 676.6K | -33% | $0 | |
| 2023-05-22 | 2023-05-18 | ZURA | Zura Bio Ltd | Cabell Christopher | CMO, Head of R, D | A - Grant | $0.00 | +162.1K | 162.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations